Faculty
Hematology Division

Kristen M. Sanfilippo, MD, MPHS
Associate Professor
Department of Medicine
Hematology Division
Clinical Interests
- Venous thromboembolism
- Cancer-associated thrombosis
- Arterial thromboembolism
- Anticoagulation
- Antiphospholipid antibody syndrome
- Pregnancy associated thrombosis
- Thrombophilia
- Hypercoagulable diseases
Research Interests
- Venous thromboembolism
- Cancer-associated thrombosis
- Anticoagulant-related bleeding
- Population health
- Outcomes research
- Big data
Contact
- 314-362-0164 (office)
- 314-362-8813 (fax)
- ksanfilippo@wustl.edu
- Hematology Division
Mail Stop 8125-0022-01
Washington University
660 South Euclid Avenue
St. Louis, MO 63110 - Suite 1101 Wohl Hospital (office)
Biosketch
Educataion | |
---|---|
1999-2003 | BS in Biology (magna cum laude), University of Missouri-Columbia, Columbia, MO |
2003-2007 | MD, University of Missouri-Columbia, Columbia, MO |
2011-2012 | MPHS (Master Population Health Science), Washington University School of Medicine, St. Louis, MO |
Post-graduate Training | |
2007-2010 | Internal Medicine Resident, University of Pittsburgh Medical Center, Pittsburgh, PA |
2010-2013 | Hematology/Oncology Fellow, Washington University School of Medicine, St. Louis, MO |
Academic Positions | |
2013-2016 | Instructor of Medicine, Hematology Division, Washington University School of Medicine, St. Louis, MO |
2013-present | Staff Physician, Hematology/Oncology, John Cochran Veterans Administration Medical Center, St. Louis, MO |
2016-2023 | Assistant Professor, Hematology Division, Washington University School of Medicine, St. Louis, MO |
2023-present | Associate Professor, Hematology Division, Washington University School of Medicine, St. Louis, MO |
University & Hospital Appointments & Committees | |
2014-present | Barnes Jewish Hospital Clinical Panel, Hematology Formulary Working Group |
2016-2018 | Washington University Department of Medicine Leader, Development of Inpatient Epic |
2017-2018 | Hematology Therapy Validation, Epic |
2017-present | Transfusion Review Committee, St. Louis VA Medical Center |
2018-present | Barnes Jewish Hospital Warfarin Working Group |
2020 | Development of BJC Guidance for Thromboprophylaxis in Hospitalized Patients with COVID-19 |
2021 | Pulmonary Embolism Response Team (PERT) Steering Committee |
2021 | Development of BJC Guidance for Vaccine-Induced Immune Thrombotic Thrombocytopenia |
Board Certification | |
2010 | American Board of Internal Medicine, Internal Medicine |
2013 | American Board of Internal Medicine, Oncology |
2014 | American Board of Internal Medicine, Hematology |
Honors & Awards | |
2000 | Phi Eta Sigma National Honor Society |
2000 | Golden Key National Honor Society |
2002 | Mortar Board Honor Society |
2003 | Phi Beta Kappa National Honor Society |
2011 | American Society of Hematology, Abstract Award, Trainee |
2012 | American Society of Hematology, Clinical Research Training Institute |
2022-2024 | American Society of Hematology, ASH Scholar Award |
Editorial Boards | |
2022-present | Research and Practice in Thrombosis and Haemostasis |
National Scientific Panels | |
2020-present | American Society of Hematology, COVID Coagulopathy Guideline Panel |
2020-present | International Society on Thrombosis and Haemostasis, Hemostasis and Malignancy Subcommittee Co-Chair |
2020-present | American Society of Hematology, Clinical Research Training Institute Faculty |
2020-present | American Society of Hematology, Subcommittee on Clinical Trials |
Professional Societies | |
2010-present | American Society of Hematology |
2010-2020 | American Society of Clinical Oncology |
2017-present | International Society on Thrombosis and Haemostasis |
2018-present | Hemostasis and Thrombosis Research Society |